Bridgepoint makes 3.3x from medtech business Acteon
Bridgepoint will see a 3.3x return from the sale of its majority stake in French medical and dental technology business Acteon, Real Deals understands.
Bridgepoint will see a 3.3x return from the sale of its majority stake in French medical and dental technology business Acteon, Real Deals understands.